<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: An elevated plasma level of C-reactive protein (CRP) is a risk for, and prognostic factor of, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In other reports of CRP concerning <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, CRP level correlated with its gene polymorphisms </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that CRP polymorphisms associate risk and prognosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: This study enrolled 421 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and 218 healthy control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>After preliminary studies, we selected four single nucleotide polymorphisms (SNPs) in the CRP gene: +2147A &gt; G (rs1205), +942G &gt; C (rs1800947), -717A &gt; G (rs2794521), and -757T &gt; C (rs3093059) </plain></SENT>
<SENT sid="5" pm="."><plain>At first, analyzing distributions of four SNPs between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> case and non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> control groups was performed </plain></SENT>
<SENT sid="6" pm="."><plain>Subsequently, the impacts of these SNPs with other prognostic factors of disease-free interval (DFI) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival (CSS) were analyzed using uni- and multivariate Cox regression analyses </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The case and control groups differed in the frequency of -757T &gt; C (P = 0.002) </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> case group had a higher percentage of the TT genotype (odds, 1.75) </plain></SENT>
<SENT sid="9" pm="."><plain>Regarding prognoses, multivariate analyses revealed that four factors, including stage (I, II, III), gross <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type (polypoid, ulcerative, infiltrative), location (right, left, rectum), and -757T &gt; C SNP (odds, 1.29; P = 0.048), correlated with DFI; two factors, including stage and +2147A &gt; G SNP (odds, 0.71; P = 0.03), correlated with CSS </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The -757T &gt; C SNP is a risk for and prognostic factor of DFI; the +2147A &gt; G SNP is a prognostic factor of CSS </plain></SENT>
<SENT sid="11" pm="."><plain>CRP polymorphisms associate the risk and survival of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>